Natural History of Tricuspid Regurgitation After Transcatheter Aortic Valve Implantation
Journal of the American Heart Association · 2025-07 · 14 (13)
DOI: 10.1161/jaha.125.040955 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of the American Heart Association, 2025-07. Verfasst von James A Brown und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiac Surgery, Department of Cardiothoracic Surgery University of Pittsburgh PA USA. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Tricuspid Valve Insufficiency, Aortic Valve Stenosis, Postoperative Complications. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Background
To determine the impact of tricuspid regurgitation (TR) on outcomes after transcatheter aortic valve implantation (TAVI), and to determine the evolution of TR severity after TAVI.
Methods
This was an observational study of TAVIs for aortic stenosis from November 2012 to December 2021. Patients were dichotomized according to the severity of pre‐TAVI TR: less than moderate versus moderate or greater. Logistic regression was used to determine the risk factors for progression or persistence of moderate or greater TR at 1 year after TAVI.
Results
A total of 2250 patients were included for analysis, of which 301 (13.4%) had moderate or greater TR before TAVI. Baseline moderate or greater TR was associated with reduced survival and a higher incidence of heart failure readmission at 5 years after TAVI. Twelve percent of patients had progression or persistence of moderate or greater TR at 1 year after TAVI. On multivariable logistic regression, increasing age, female sex, lower mean pre‐TAVI aortic transvalvular pressure gradient, pulmonary artery systolic pressure ≥40 mm Hg, pulmonary vascular disease, and transfemoral vascular access were associated with progression or persistence of moderate or greater TR at 1 year after TAVI, while periprocedural variables related to valve implantation were not.
Conclusions
Significant TR before TAVI was associated with poor outcomes after TAVI. The incidence of moderate or greater TR at 1 year after TAVI was reasonable at 12%. Periprocedural factors, such as valve size, type of implanted valve, and paravalvular leak, were not associated with the development of TR. Evolution of TR and heart failure symptoms must be carefully surveilled after TAVI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiac Surgery, Department of Cardiothoracic Surgery University of Pittsburgh PA USA.
- Heart and Vascular Institute, University of Pittsburgh Medical Center Pittsburgh PA USA.
- Division of Cardiology, Department of Medicine University of Pittsburgh PA USA.
ORCID-Profile: James A Brown, Sarah Yousef, Derek Serna-Gallegos, Amber Makani, Takuya Ogami, Ibrahim Sultan
Förderung
- NHLBI NIH HHS
Zitieren
APA
Brown, J. A., Donohue, J., Yousef, S., Iyanna, N., Ahmad, D., Kliner, D., Toma, C., Serna-Gallegos, D., Makani, A., West, D., Hasan, I., Ogami, T., & Sultan, I. (2025). Natural History of Tricuspid Regurgitation After Transcatheter Aortic Valve Implantation. Journal of the American Heart Association, 14(13). https://doi.org/10.1161/jaha.125.040955
Vancouver
Brown JA, Donohue J, Yousef S, Iyanna N, Ahmad D, Kliner D, et al. Natural History of Tricuspid Regurgitation After Transcatheter Aortic Valve Implantation. Journal of the American Heart Association. 2025;14(13). doi:10.1161/jaha.125.040955
BibTeX
@article{Brown2025,
author = {Brown, James A and Donohue, Jack and Yousef, Sarah and Iyanna, Nidhi and Ahmad, Danial and Kliner, Dustin and Toma, Catalin and Serna-Gallegos, Derek and Makani, Amber and West, David and Hasan, Irsa and Ogami, Takuya and Sultan, Ibrahim},
title = {Natural History of Tricuspid Regurgitation After Transcatheter Aortic Valve Implantation},
journal = {Journal of the American Heart Association},
year = {2025},
volume = {14},
number = {13},
doi = {10.1161/jaha.125.040955}
}
EUVIMED